Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology.

Keikes L, Medlock S, van de Berg DJ, Zhang S, Guicherit OR, Punt CJA, van Oijen MGH.

J Clin Transl Res. 2018 Jul 27;3(Suppl 3):411-423. eCollection 2018 Dec 17.

2.

Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures.

Sirenko O, Parham F, Dea S, Sodhi N, Biesmans S, Mora-Castilla S, Ryan K, Behl M, Chandy G, Crittenden C, Vargas-Hurlston S, Guicherit O, Gordon R, Zanella F, Carromeu C.

Toxicol Sci. 2019 Jan 1;167(1):58-76. doi: 10.1093/toxsci/kfy218.

PMID:
30169818
3.

Weekend Effect in Emergency Colon and Rectal Cancer Surgery: A Prospective Study Using Data From the Dutch ColoRectal Audit.

Huijts DD, van Groningen JT, Guicherit OR, Dekker JWT, van Bodegom-Vos L, Bastiaannet E, Govaert JA, Wouters MW, de Mheen PJM.

J Natl Compr Canc Netw. 2018 Jun;16(6):735-741. doi: 10.6004/jnccn.2018.7016.

PMID:
29891525
4.

Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care.

Kool M, van der Sijp JR, Kroep JR, Liefers GJ, Jannink I, Guicherit OR, Vree R, Bastiaannet E, van de Velde CJ, Marang-van de Mheen PJ.

Breast. 2016 Jun;27:62-8. doi: 10.1016/j.breast.2016.02.015. Epub 2016 Mar 26.

PMID:
27026219
5.
6.

Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.

Belmont PJ, Jiang P, McKee TD, Xie T, Isaacson J, Baryla NE, Roper J, Sinnamon MJ, Lee NV, Kan JL, Guicherit O, Wouters BG, O'Brien CA, Shields D, Olson P, VanArsdale T, Weinrich SL, Rejto P, Christensen JG, Fantin VR, Hung KE, Martin ES.

Sci Signal. 2014 Nov 11;7(351):ra107. doi: 10.1126/scisignal.2005516.

PMID:
25389372
7.

Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a critical role in triple-negative breast cancer.

Kung PP, Martinez R, Zhu Z, Zager M, Blasina A, Rymer I, Hallin J, Xu M, Carroll C, Chionis J, Wells P, Kozminski K, Fan J, Guicherit O, Huang B, Cui M, Liu C, Huang Z, Sistla A, Yang J, Murray BW.

Mol Cancer Ther. 2014 Aug;13(8):2104-15. doi: 10.1158/1535-7163.MCT-14-0083-T. Epub 2014 Jun 13.

8.

Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study.

Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ, Guicherit OR, Merkus JW, Extermann M, van de Velde CJ, Liefers GJ.

Breast Cancer Res Treat. 2014 May;145(1):185-92. doi: 10.1007/s10549-014-2917-7. Epub 2014 Mar 28.

PMID:
24676624
9.

[Embolisation in spontaneous haemopneumothorax].

Gorter EA, Dubois EF, Guicherit OR, Urlings TA, de Mol van Otterloo JC.

Ned Tijdschr Geneeskd. 2012;156(20):A4425. Dutch.

PMID:
22607841
10.

Enhancing the quality of care for patients with breast cancer: seven years of experience with a Dutch auditing system.

Veerbeek L, van der Geest L, Wouters M, Guicherit O, Does-den Heijer A, Nortier J, Marinelli A, Tollenaar R, Struikmans H.

Eur J Surg Oncol. 2011 Aug;37(8):714-8. doi: 10.1016/j.ejso.2011.03.003. Epub 2011 Apr 1.

PMID:
21458947
11.

[Chylous ascites].

Bouwman LH, Wiendels DR, Rebergen SA, Guicherit OR.

Ned Tijdschr Geneeskd. 2009;153:B92. Dutch.

PMID:
20051146
12.

Potent agonists of the Hedgehog signaling pathway.

Brunton SA, Stibbard JH, Rubin LL, Guicherit OM, Kruse LI, Price S, di Lucrezia R, MacKinnon CH, Avery A, Park Y, Buxton D, Boyd EA.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4308-11. doi: 10.1016/j.bmcl.2009.05.096. Epub 2009 May 29.

PMID:
19500978
13.

[Chylous ascites].

Bouwman LH, Wiendels DR, Rebergen SA, Guicherit OR.

Ned Tijdschr Geneeskd. 2009 May 9;153(19):932-6. Dutch. No abstract available.

PMID:
19489300
14.

Volume- or outcome-based referral to improve quality of care for esophageal cancer surgery in The Netherlands.

Wouters MW, Krijnen P, Le Cessie S, Gooiker GA, Guicherit OR, Marinelli AW, Kievit J, Tollenaar RA.

J Surg Oncol. 2009 Jun 15;99(8):481-7. doi: 10.1002/jso.21191. Review.

PMID:
19466737
15.

Potent inhibitors of the hedgehog signaling pathway.

Brunton SA, Stibbard JH, Rubin LL, Kruse LI, Guicherit OM, Boyd EA, Price S.

J Med Chem. 2008 Mar 13;51(5):1108-10. doi: 10.1021/jm070694n. Epub 2008 Feb 15.

PMID:
18275133
16.

Intussusception in adults: report of four cases and review of the literature.

Duijff JW, van der Burg BL, Aarts NJ, Loyson SA, Guicherit OR.

Case Rep Gastroenterol. 2007 Aug 20;1(1):59-64. doi: 10.1159/000107473.

17.

IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling.

Li C, Chi S, He N, Zhang X, Guicherit O, Wagner R, Tyring S, Xie J.

Oncogene. 2004 Feb 26;23(8):1608-17.

PMID:
14647422
18.

Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.

Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Wichterle H, Kon C, Gatchalian C, Porter JA, Rubin LL, Wang FY.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4616-21. Epub 2003 Apr 4. Erratum in: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8607.

19.

Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.

Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, Rubin LL, Porter JA.

J Biol. 2002 Nov 6;1(2):10.

20.

[One hundred years of the Association of Surgeons in the Netherlands. VI. The training].

Guicherit OR, Bruijninckx CM, van Schilfgaarde R.

Ned Tijdschr Geneeskd. 2002 Jun 29;146(26):1238-42. Dutch.

PMID:
12132142
21.

Sonic hedgehog is a potent inducer of rat oligodendrocyte development from cortical precursors in vitro.

Murray K, Calaora V, Rottkamp C, Guicherit O, Dubois-Dalcq M.

Mol Cell Neurosci. 2002 Mar;19(3):320-32.

PMID:
11906206
22.

Transcriptional control: rheostat converted to on/off switch.

Rossi FM, Kringstein AM, Spicher A, Guicherit OM, Blau HM.

Mol Cell. 2000 Sep;6(3):723-8.

23.

The relative contribution of insulin secretory capacity, insulin action, and incretins to metabolic control after islet transplantation in dogs.

van der Burg MP, van Suylichem PT, Guicherit OR, Frölich M, Lemkes HH, Gooszen HG.

J Mol Med (Berl). 1999 Jan;77(1):104-6.

PMID:
9930939
24.

Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16.

Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT, Blau HM.

Nat Genet. 1998 Dec;20(4):389-93.

PMID:
9843215
25.

Highly conserved RNA sequences that are sensors of environmental stress.

Spicher A, Guicherit OM, Duret L, Aslanian A, Sanjines EM, Denko NC, Giaccia AJ, Blau HM.

Mol Cell Biol. 1998 Dec;18(12):7371-82.

26.

Glucoregulation after canine islet transplantation: contribution of insulin secretory capacity, insulin action, and the entero-insular axis.

van der Burg MP, van Suylichem PT, Guicherit OR, Frölich M, Lemkes HH, Gooszen HG.

Cell Transplant. 1997 Sep-Oct;6(5):497-503.

PMID:
9331501
27.

Structure and expression of the murine muscle adenylosuccinate synthetase gene.

Lewis AL, Guicherit OM, Datta SK, Hanten GR, Kellems RE.

J Biol Chem. 1996 Sep 13;271(37):22647-56.

28.

Function and survival of intrasplenic islet autografts in dogs.

van der Burg MP, Guicherit OR, Jansen JB, Frölich M, Lamers CB, Lemkes HH, Bruijn JA, Gooszen HG.

Diabetologia. 1996 Jan;39(1):37-44.

PMID:
8720601
29.
30.

Glycemic control mechanisms after canine islet autografting.

van der Burg MP, van Suylichem PT, Guicherit OR, Frölich M, Lemkes HH, Gooszen HG.

Transplant Proc. 1995 Dec;27(6):3187-8. No abstract available.

PMID:
8539903
31.

Adenylosuccinate synthetase: a dominant amplifiable genetic marker in mammalian cells.

Datta SK, Guicherit OM, Kellems RE.

Somat Cell Mol Genet. 1994 Sep;20(5):381-9.

PMID:
7825060
32.

Cell preservation in University of Wisconsin solution during isolation of canine islets of Langerhans.

van der Burg MP, Guicherit OR, Frölich M, Prins FA, Bruijn JA, Gooszen HG.

Cell Transplant. 1994 Jul-Aug;3(4):315-24.

PMID:
7921636
33.

Morphometry of native and isolated canine islets: a new approach to isolation assessment.

van der Burg MP, Guicherit OR, Frölich M, Scherft JP, Prins FA, Bruijn JA, Gooszen HG.

Transplant Proc. 1994 Apr;26(2):632-3. No abstract available.

PMID:
7513459
34.

Renal morphological changes in dogs with systemic venous drainage of the pancreas.

Tamsma JT, Guicherit OR, Lemkes HH, van der Woude FJ, Frölich M, Bruijn JA, Gooszen HG.

Transplantation. 1994 Mar 15;57(5):768-70. No abstract available.

PMID:
8140645
36.

Assessment of islet isolation efficacy in dogs.

van der Burg MP, Guicherit OR, Frölich M, Scherft JP, Prins FA, Bruijn JA, Gooszen HG.

Cell Transplant. 1994 Jan-Feb;3(1):91-101.

PMID:
8162296
37.

Impact of donor-related variables on islet isolation outcome in dogs.

van der Burg MP, Guicherit OR, Frölich M, Scherft JP, Bruijn JA, Gooszen HG.

Diabetologia. 1994 Jan;37(1):111-4.

PMID:
8150223
38.

The muscle and nonmuscle isozymes of adenylosuccinate synthetase are encoded by separate genes with differential patterns of expression.

Guicherit OM, Cooper BF, Rudolph FB, Kellems RE.

Adv Exp Med Biol. 1994;370:585-90. No abstract available.

PMID:
7660974
39.

The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine.

Mohamedali KA, Guicherit OM, Kellems RE, Rudolph FB.

J Biol Chem. 1993 Nov 5;268(31):23728-33.

40.

Islet preservation during isolation: a new concept in cell transplantation.

van der Burg MP, Guicherit OR, Frölich M, Bruijn JA, Gooszen HG.

Transplant Proc. 1992 Dec;24(6):2840-1. No abstract available.

PMID:
1465965
41.

Molecular cloning and expression of a mouse muscle cDNA encoding adenylosuccinate synthetase.

Guicherit OM, Rudolph FB, Kellems RE, Cooper BF.

J Biol Chem. 1991 Nov 25;266(33):22582-7.

42.

Metabolic control after autotransplantation of highly purified canine pancreatic islets isolated in UW solution.

van der Burg MP, Guicherit OR, Ploeg RJ, Frölich M, Bruijn JA, Scherft JP, Gooszen HG.

Transplant Proc. 1991 Feb;23(1 Pt 1):785-6. No abstract available.

PMID:
1990691
43.

Pancreatic islet isolation with UW solution: a new concept.

van der Burg MP, Gooszen HG, Ploeg RJ, Guicherit OR, Scherft JP, Terpstra JL, Bruijn JA, Frölich M.

Transplant Proc. 1990 Aug;22(4):2050-1. No abstract available.

PMID:
2202137
44.

Comparison of current islet isolation techniques in dogs.

van der Burg MP, Gooszen HG, Field MJ, Scherft JP, Terpstra JL, van de Woude FJ, Guicherit OR, Frölich M, Bruijn JA.

Transplant Proc. 1990 Aug;22(4):2044-5. No abstract available.

PMID:
1697121
45.

Comparison of islet isolation techniques in dogs: over 90% purified islets using UW solution.

van der Burg MP, Gooszen HG, Ploeg RJ, Scherft JP, Field MJ, Guicherit OR, Terpstra JL, van de Woude FT, Frölich M, Bruijn JA.

Transplant Proc. 1990 Apr;22(2):795-6. No abstract available.

PMID:
2158174
46.

Endocrine function of the pancreas after transplantation: the contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation by the canine pancreas.

Gooszen HG, van der Burg MP, Guicherit OR, Jansen JB, Frölich M, van Haastert FA, Lamers CB.

Transplant Proc. 1990 Apr;22(2):712-5. No abstract available.

PMID:
2109390
47.
48.

Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation.

van der Burg MP, Gooszen HG, Guicherit OR, Jansen JB, Frölich M, van Haastert FA, Lamers CB.

Diabetes. 1989 Sep;38(9):1082-9.

PMID:
2670640
49.

Crossover study on effects of duct obliteration, celiac denervation, and autotransplantation on glucose- and meal-stimulated insulin, glucagon, and pancreatic polypeptide levels.

Gooszen HG, van der Burg MP, Guicherit OR, Jansen JB, Frölich M, van Schilfgaarde R, Lamers CB.

Diabetes. 1989 Jan;38 Suppl 1:114-6.

PMID:
2642831

Supplemental Content

Loading ...
Support Center